SBIO Pte. Ltd.
This article was originally published in Start Up
SBIO Pte. Ltd. was founded in 2000 as a joint venture between Chiron and the Singapore Economic Development Board Investments. The mission was to start a research center that would eventually become more of an independent biotech. In the intervening years, SBIO has developed expertise in a wide variety of fields, including computational chemistry, molecular screening, chemical synthesis, protein biology, biomarkers, and disease models, as well as clinical and regulatory functions. SBIO now bills itself as Singapore's "first fully integrated drug discovery company."
You may also be interested in...
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Inflammation: A Hot Space Gets Complicated," features profiles of CellAct Pharma, Kineta and Lycera. Plus these Start-Ups Across Health Care: BioLeap, Integrated Diagnostics, Nightingale-EOS, SBIO, Spirus Medical and Varix Medical.
Gene editing has made a great many headlines of late, and one could be forgiven for thinking the field was saturated, but Homology Medicines Inc. offers something new. Its platform relies on a different mechanism, known as homologous recombination, and the start-up's management team believes the approach can get around some of the potential limitations found in other gene-editing technologies.